CXCL12 and infarction: Recently, we suggested that the administration of DPP-4 inhibitors may be beneficial in myocardial repair following infarction by the preservation of stem cell chemoattractant stromal cell-derived factor-1 (SDF-1) (Anderluh et al., 2016).